Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study
Authors:
- 1 June 2021
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 32 (11) , 2365-2369
Abstract
Summary The only difference between fractured and non-fractured postmenopausal women with PHPT of same sex, age, and BMI was a significantly mean higher serum k-periostin level. K-periostin value was associated with fracture at any site (odds ratio 1.044, 95% CI 1.005–1.091, p = 0.03). Introduction To assess serum k-periostin fragment levels in patients with primary hyperparathyroidism (PHPT), fractured and non-fractured matched for sex, age, and body mass index. Methods Twenty-five Caucasian fractured postmenopausal women with PHPT (group Fx) and 25 PHPT non-fractured (group NFx) were enrolled. Each patient underwent DXA scan at lumbar, hip, and forearm, spine X-ray, and biochemical evaluation of calcium metabolism. For k-periostin analyses, we utilized a specific ELISA test that detects CatK-generated fragment levels in the bloodstream. Results We found no difference in mean BMD and bone turnover marker values between Fx and NFx groups. Prevalence of osteoporosis was not significantly different in Fx vs NFx (72% vs 60%, p = 0.55). Among Fx, 16% reported multiple fractures, 28% morphometric vertebral fractures, 4% femoral fractures, 28% non-vertebral non-femoral fractures, and 8% wrist fractures. The only detectable difference between Fx and NFx group was a significantly mean higher k-periostin serum level (46.2 ± 21.4 vs 34.7 ± 13.5 ng/ml, p = 0.02). K-periostin was associated with fracture at any site (odds ratio 1.044, 95% CI 1.005–1.091, p = 0.03). No difference in mean k-periostin values was found between patients with vertebral fracture vs those with non-vertebral fracture, and between those with multiple fractures vs those with single fracture. Conclusion Serum k-periostin is significantly associated with fracture in PHPT. If confirmed by further studies, k-periostin could be considered a new marker of bone fragility in PHPT, independently of BMD.Keywords
This publication has 19 references indexed in Scilit:
- Periostin action in boneMolecular and Cellular Endocrinology, 2016
- Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal siteBone, 2015
- Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone MicrostructureThe Journal of Clinical Endocrinology & Metabolism, 2015
- Prevalence of Kidney Stones and Vertebral Fractures in Primary Hyperparathyroidism Using Imaging TechnologyThe Journal of Clinical Endocrinology & Metabolism, 2015
- Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based studyEuropean Journal of Endocrinology, 2014
- Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY StudyThe Journal of Clinical Endocrinology & Metabolism, 2014
- “Trabecular Bone Score” (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidismBone, 2013
- Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: A one-year prospective controlled study using high-resolution peripheral quantitative computed tomographyJournal of Bone and Mineral Research, 2012
- Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidismBone, 2006
- Biomarkers of Bone Turnover after a Short Period of Steroid Therapy in Elderly MenClinical Chemistry, 2001